We validated mRNA expression levels of TCF7L1 in an RNA-Seq dataset (GSE48403) in paired PCa samples pre- and post-ADT, and found that post-ADT patients had increased TCF7L1 expression in the GSE48403 dataset (Fig. 3C), consistent with our data. This evidence concerns the gene TCF7L1 and posterior cortical atrophy.